Smart Medical Devices Market - By Product Type By End Use, By Distribution Channel, & Global Forecast, 2024 – 2032

Smart Medical Devices Market Size

The global smart medical devices market was valued at around USD 38 billion in 2023 and is expected to reach around USD 129.2 billion by 2032 at a CAGR of 14.3% during the forecast period.
 

The market is witnessing robust growth due to the increasing adoption of smartphone-compatible and wireless medical devices, alongside rising awareness and focus on health and fitness. The surge in healthcare concerns, the prevalence of chronic diseases, increased healthcare spending, and the high demand for wearable devices are key drivers accelerating market expansion.
 

Wearable medical equipment such as sensors, ECG devices, and fitness-tracking smartwatches are in high demand because they are easy to use and do not require expert interpretation. These devices enable users, especially the elderly, to monitor their vital signs from home without frequent clinic or hospital visits, enhancing convenience and promoting widespread adoption among older populations.
 

The growing importance of real-time data-driven approaches for diagnostics and treatment in hospitals & diagnostic centers is fostering the smart medical devices market progress. Prominent technological developments in healthcare, along with the adoption of innovative solutions to achieve better patient outcomes, are driving medical devices which are speculated to accelerate industry expansion.
 

Smart medical devices are advanced healthcare tools that use technology to monitor, diagnose, or treat medical conditions. These devices are often connected to smartphones, tablets, or other wireless systems, enabling real-time data collection, analysis, and communication. Smart medical devices include wearables like fitness trackers, smartwatches, glucose monitors, ECG sensors, and blood pressure monitors, as well as implantable or portable devices.
 

Smart Medical Devices Market Trends

The smart medical devices industry is experiencing strong growth due to advancements in technology, rising demand for remote monitoring, and increasing focus on personalized healthcare.
 

• Wearable devices such as smartwatches, fitness trackers, and biosensors are gaining popularity for monitoring health metrics like heart rate, blood pressure, glucose levels, and sleep patterns. These devices provide real-time data for proactive health management.
   
• Devices for measuring blood glucose, heart rate, and ECG are designed to be user-friendly, especially for elderly individuals or those with limited technology experience. They feature simple navigation and seamless smartphone connectivity, making health monitoring accessible to a wider audience.
   
• Key industry players are investing heavily in research and development. For example, Apple’s Watch Series has continually improved over the years, with features like heart rate notifications and irregular rhythm detection.
   
• In developing countries like India and South Africa, the rising prevalence of diseases due to lifestyle factors is driving the adoption of smart medical devices.
   
• The growing prevalence of chronic diseases like diabetes and asthma is boosting market demand. According to WHO, 10% of adults globally may have diabetes by 2045, increasing the need for devices like glucose monitors and insulin pumps. Additionally, conditions such as multiple sclerosis (MS) and chronic obstructive pulmonary disease (COPD) are further driving the development and adoption of smart medical devices for monitoring and treatment.
   

Smart Medical Devices Market Analysis

Based on product type, the market is classified into diagnostic and monitoring devices, therapeutic devices and other product types. The diagnostic and monitoring segment was valued at USD 25.8 billion in 2023. The diagnostic and monitoring devices segment is further divided into blood glucose monitors, heart rate monitors, pulse oximeters, blood pressure monitors, breathalyzers, and other diagnostic & monitoring devices. The therapeutic devices segment is further segmented into portable oxygen concentrators and ventilators, insulin pumps, hearing aid, and other therapeutic devices. Favourable government measures to enhance patient care as well as rising investments in the smart medical devices sector are contributing to segment expansion.
 

• Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders require continuous monitoring. Smart diagnostic and monitoring devices provide patients and healthcare providers with real-time data, enabling better disease management and timely interventions.
   
• The development of advanced sensors has significantly enhanced the capabilities of diagnostic and monitoring devices. These sensors can accurately measure various physiological parameters, such as glucose levels, blood pressure, heart rate, and oxygen saturation, facilitating more precise and reliable monitoring.
   
• The market players in this segment are focusing on product development strategies. For instance, In July 2022, Medtronic launched MiniMed 780G system in India. The Minimed 780G is a next-generation closed-loop insulin pump system for treating type 1 diabetes in people aged seven to 80. Later in September 2020, Medtronic received U.S. Food and Drug Administration approval for its MiniMed 770G insulin pump system built on the 670G system. The 770G features smartphone connectivity and is embedded with indications for ages 2 and above. Thus, owing to the advantages mentioned above of using insulin pumps and the increasing prevalence of diabetes worldwide, the insulin pump segment is expected to register growth over the forecast period.
   
• CGMs are a prime example of smart monitoring devices that have revolutionized diabetes management. These devices continuously measure glucose levels in real-time, providing valuable insights for patients to manage their condition more effectively.
   

Based on end use, the smart medical devices market is classified into hospitals, homecare setting, and other end users. The homecare setting segment is anticipated to depict over 14.5% CAGR from 2023 to 2032. The growing aging population globally and soaring patient demand for value-based healthcare in their homes is slated to fuel segment progress. As per WHO, the total number of people aged above 60 or older would reach 1.4 billion by the year 2030. This is expected to boost the demand for patient-centred healthcare services, especially in-home care services.
 

• The global population is aging, leading to a higher prevalence of chronic diseases and age-related health conditions. Smart medical devices designed for homecare enable elderly individuals to monitor their health, manage chronic conditions, and maintain independence, reducing the need for frequent hospital visits.
   
• Chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions require continuous monitoring and management. Homecare smart medical devices provide patients with the tools to track their health parameters regularly, facilitating better disease management and early intervention.
   
• Advancements in sensor technology, wireless communication, and data analytics have enhanced the capabilities of homecare medical devices. These devices are now more accurate, reliable, and user-friendly, making them suitable for home use by patients of all ages.
   
• The COVID-19 pandemic accelerated the adoption of remote monitoring and telehealth solutions. With social distancing measures and the need to reduce hospital visits, many patients and healthcare providers turned to homecare smart medical devices for continuous monitoring and virtual consultations.
   

The distribution channel segment includes brick & mortar and e-commerce. E-commerce is the fastest-growing segment with a CAGR of 17.1% during the forecast period, owing to an increase in online purchasing through smartphones, higher flexibility, and easier availability of a wide range of products.
 

• The shift towards online sales channels for medical devices is driven by several factors, including the convenience of online shopping, the wide range of available products, and the ability to compare prices and read reviews.
   
• E-commerce platforms provide a convenient and accessible way for consumers to purchase smart medical devices. Patients can order devices from the comfort of their homes, eliminating the need to visit physical stores or healthcare facilities.
   
• Online marketplaces offer a vast selection of smart medical devices, from wearable fitness trackers to advanced diagnostic tools. Consumers can easily find and purchase the specific devices they need, often with more options than available in traditional brick-and-mortar stores.
   
• E-commerce platforms allow consumers to compare prices across different sellers and read reviews from other buyers. This transparency helps consumers make informed purchasing decisions and find the best value for their money.
   
• The availability of home delivery services makes it easy for consumers to receive their devices quickly and conveniently. Additionally, subscription models for certain medical supplies and devices ensure regular, hassle-free deliveries.
   
• The rise of telehealth and online health services has driven more consumers to seek out smart medical devices online. These devices are often recommended by telehealth providers, leading to direct purchases from e-commerce platforms.
   

North America smart medical devices market accounted for USD 13.9 billion in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America is at the forefront of technological innovation in healthcare. Advances in wearable technology, sensor accuracy, artificial intelligence (AI), and data analytics are driving the development and adoption of smart medical devices. These technologies enhance the functionality, reliability, and user-friendliness of the devices, making them more attractive to both healthcare providers and patients.
   
• The aging population in North America is a significant driver of the smart medical devices market. Older adults are more likely to have chronic conditions that require continuous monitoring and management. Smart medical devices provide a means to monitor health parameters remotely, reducing the need for frequent hospital visits and enabling seniors to maintain their independence.
   
• Additionally, most of the major players, such as Garmin Ltd, Fitbit, Inc, and Biotelemetry, Inc, are concentrated in this region and have been investing in the research and development of smart medical devices launching innovative products in this region. For instance, in August 2020, Fitbit, Inc. launched Fitbit Sense, an advanced health smart watch that helps detect the body's responses to stressors by measuring electrodermal activity responses. Thus, owing to these factors, the market is expected to grow significantly in North America over the forecast period.
   

Smart Medical Devices Market Share

The smart medical devices industry is moderately competitive, and few companies hold most of the market share. New players are coming up in the market due to the technological advancements in the healthcare industry and the rising R&D expenditure of the companies. Some of the companies which are currently dominating the market are Abbott laboratories, Apple, Bio-beat, Dexcom, F. Hoffmann la Roche, Fitbit, Medtronic, Neurometric, Omron Corporation, Otsuka Holdings, Koninklijke Philips N.V., Vital Connect, Samsung and others.
 

Smart Medical Devices Market Companies

Some of the eminent market participants operating in the smart medical devices industry include:

• Abbott
• Apple
• Biobeat
• Boston Scientific Corporation
• Dexcom
• F Hoffmann-La Roche
• Fitbit
• Medtronic
• NeuroMetrix
• Novo Nordisk
• Omron Corporation (Omron Healthcare)
• SAMSUNG
• VitalConnect
•  West Pharmaceutical Services
   

Smart Medical Devices Industry News:

• In May 2021, GOQii launched GOQii Vital 4, the latest fitness band with a SpO2 and blood pressure monitor, and tracks all-day activity like steps, distance, and the calories burned. This product launch helped the company by significantly driving the sales and enhancing brand reputation.
   
• In January 2021, Facedrive Health launched V2 TraceSCAN Wearable Device. TraceSCAN V2 features an extensive set of improved functionalities to offer key health and safety advantages while enhancing the usual shortcomings of typical Bluetooth devices (which are not GPS-based), such as privacy considerations, accuracy, data management, and vital signs monitoring capability. This helped the company set new standards in the industry and fostering customer loyalty.
   

Smart medical devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Diagnostic and monitoring devices
  • Blood glucose monitors
  • Heart rate monitors
  • Pulse oximeters
  • Blood pressure monitors
  • Breathalyzers
  • Other diagnostic and monitoring devices
• Therapeutic devices 
  • Portable oxygen concentrators and ventilators
  • Insulin pumps
  • Hearing aid
  • Other therapeutic devices
• Other product types

Market, By End Use

• Hospitals
• Homecare settings
• Other end users

Market, By Distribution Channel

• Brick & mortar
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE